The ARF-B23 connection: implications for growth control and cancer treatment

Yanping Zhang1

  • 1Department of Molecular and Cellular Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. ypzhang@mdanderson.org

Insights

The tumor suppressor ARF protein halts cell cycle progression through p53-dependent and -independent pathways. It also inhibits cell growth by targeting nucleolar protein B23, coordinating proliferation and growth suppression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The tumor suppressor ARF protein plays a critical role in cell cycle regulation.
  • ARF exhibits both p53-dependent and p53-independent mechanisms for inducing cell cycle arrest.
  • ARF's localization in the nucleolus and its p53-independent functions are areas of ongoing research.

Purpose of the Study:

  • To investigate the molecular target and mechanism of ARF's p53-independent function.
  • To elucidate ARF's role in the nucleolus and its impact on cell growth.
  • To understand how ARF coordinates cell growth and proliferation inhibition.

Main Methods:

  • The study identified the nucleolar protein B23 as a molecular target of ARF.
  • Investigated ARF's interaction with B23 to understand growth inhibition.
  • Examined ARF's role in both the MDM2-p53 pathway and ribosomal biogenesis.

Main Results:

  • ARF targets the nucleolar protein B23 to execute its growth inhibitory function.
  • ARF blocks cell cycle progression via the MDM2-p53 pathway.
  • ARF suppresses ribosomal biogenesis through its interaction with B23.

Conclusions:

  • ARF coordinates the inhibition of cell growth and proliferation.
  • ARF's dual targeting of cell cycle machinery (MDM2-p53) and ribosomal biogenesis (B23) highlights its central role in growth control.
  • Further research into ARF's nucleolar functions is warranted.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...